Cryo-Cell International Inc (CCEL) stock
CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
$4.85−0.55 (-10.19%)
Close on Nov 13, 2026Market cap $39.10MP/E –Yield –
Cryo-Cell International operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cryo-Cell International's operating cash flow for the twelve months ending Aug 31, 2026 was $4.92M, down 22.6% year over year. For fiscal 2025 it was $5.48M, down 8.9% from the year before. Over ten years it grew 1.2% a year on average. The highest annual figure on record is $8.92M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $5.48M | -8.9% |
| FY2024 | Nov 30, 2024 | $6.01M | -32.6% |
| FY2023 | Nov 30, 2023 | $8.92M | +4.0% |
| FY2022 | Nov 30, 2022 | $8.57M | +8.2% |
| FY2021 | Nov 30, 2021 | $7.93M | -6.4% |
| FY2020 | Nov 30, 2020 | $8.47M | +34.5% |
| FY2019 | Nov 30, 2019 | $6.29M | +18.0% |
| FY2018 | Nov 30, 2018 | $5.33M | -6.7% |
| FY2017 | Nov 30, 2017 | $5.72M | +14.6% |
| FY2016 | Nov 30, 2016 | $4.99M | +2.8% |
| FY2015 | Nov 30, 2015 | $4.85M | +212.0% |
| FY2014 | Nov 30, 2014 | $1.55M | +89.2% |
| FY2013 | Nov 30, 2013 | $821.98K | +127.8% |
| FY2012 | Nov 30, 2012 | $360.90K | -55.9% |
| FY2011 | Nov 30, 2011 | $819.12K | -65.0% |
| FY2010 | Nov 30, 2010 | $2.34M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | $1.14M | -55.0% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | $1.85M | +161.1% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | $651.83K | -31.7% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | $1.28M | -40.6% |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | $2.54M | +4.1% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | $707.01K | -60.1% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | $954.06K | – |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | $2.16M | -35.5% |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | $2.44M | +25.5% |
| Q2 FY2024CQ2 2024 | May 31, 2024 | $1.77M | -10.8% |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | -$356.87K | -121.7% |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | $3.34M | +37.6% |
| Q3 FY2023CQ3 2023 | Aug 31, 2023 | $1.94M | -27.8% |
| Q2 FY2023CQ2 2023 | May 31, 2023 | $1.99M | +2.2% |
| Q1 FY2023CQ1 2023 | Feb 28, 2023 | $1.64M | +9.1% |
| Q4 FY2022CQ4 2022 | Nov 30, 2022 | $2.43M | +45.7% |
| Q3 FY2022CQ3 2022 | Aug 31, 2022 | $2.69M | +30.6% |
| Q2 FY2022CQ2 2022 | May 31, 2022 | $1.95M | +26.7% |
| Q1 FY2022CQ1 2022 | Feb 28, 2022 | $1.51M | -43.4% |
| Q4 FY2021CQ4 2021 | Nov 30, 2021 | $1.67M | -44.0% |
| Q3 FY2021CQ3 2021 | Aug 31, 2021 | $2.06M | +0.4% |
| Q2 FY2021CQ2 2021 | May 31, 2021 | $1.54M | +87.0% |
| Q1 FY2021CQ1 2021 | Feb 28, 2021 | $2.66M | +1.8% |
| Q4 FY2020CQ4 2020 | Nov 30, 2020 | $2.98M | +164.7% |
| Q3 FY2020CQ3 2020 | Aug 31, 2020 | $2.05M | -26.4% |
| Q2 FY2020CQ2 2020 | May 31, 2020 | $822.19K | +55.8% |
| Q1 FY2020CQ1 2020 | Feb 29, 2020 | $2.62M | +41.1% |
| Q4 FY2019CQ4 2019 | Nov 30, 2019 | $1.12M | +33.2% |
| Q3 FY2019CQ3 2019 | Aug 31, 2019 | $2.79M | +0.8% |
| Q2 FY2019CQ2 2019 | May 31, 2019 | $527.68K | +1547.4% |
| Q1 FY2019CQ1 2019 | Feb 28, 2019 | $1.85M | +9.6% |
| Q4 FY2018CQ4 2018 | Nov 30, 2018 | $843.99K | -60.0% |
| Q3 FY2018CQ3 2018 | Aug 31, 2018 | $2.77M | +125.9% |
| Q2 FY2018CQ2 2018 | May 31, 2018 | $32.03K | -98.4% |
| Q1 FY2018CQ1 2018 | Feb 28, 2018 | $1.69M | +294.3% |
| Q4 FY2017CQ4 2017 | Nov 30, 2017 | $2.11M | -17.6% |
| Q3 FY2017CQ3 2017 | Aug 31, 2017 | $1.22M | – |
| Q2 FY2017CQ2 2017 | May 31, 2017 | $1.95M | – |
| Q1 FY2017CQ1 2017 | Feb 28, 2017 | $429.06K | – |
| Q4 FY2016CQ4 2016 | Nov 30, 2016 | $2.56M | – |
See a number that looks wrong?